SEC Form 4 · accession 0001567619-18-006573
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett Sandercock
Officer — Chief Financial Officer
Period of report
Nov 14, 2018
Accepted (ET)
Nov 16, 2018 · 8:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF2 | Nov 15, 2018 | S | 2,000 | $101.44 | D | 72,156 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF3 | $101.64 | Nov 14, 2018 | A | 22,883 | A | Nov 11, 2019 | Nov 14, 2025 | ResMed Common Stock | 22,883 | 22,883 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 Plan.
- F2Includes 134.30 shares of ResMed stock purchased on October 31, 2018, through the ResMed Employee Stock Purchase Plan.
- F3Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2019, 2020 and 2021.